When a promoter of the albumin gene was used, LPDK1KO mice exhibited marked hyperinsulinemia, postprandial hyperglycemia, and lower expression levels of SREBP1c in the randomly fed condition, without liver damage or shortening of the life span [151]. The gene discussed is SREBF1; the disease is Hyperglycemia.